surmount tirzepatide trials as Compared with Semaglutide for the Treatment of Obesity SURMOUNT‐1 study design. This is
Description
Combining two GLP-1 RAs could potentially increase the risk of side effects and may not provide significant additional benefits for weight loss
These events were further categorized into sleep disorders, anxiety, and depression
Most of them are mild and usually go away in no time, however, if these side effects persist or become severe, please contact your healthcare provider who prescribed the medication immediately
Fukami A, Seino Y, Ozaki N, Yamamoto M, Sugiyama C, Sakamoto-Miura E, TatsuhitoHimeno TY, Tsunekawa S, Ali S, Drucker DJ, Murata Y, Seino Y, Oiso Y, Hayashi Y
Receive your GLP-1 prescription
